DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Accord healthcare
03 1Aurobindo Pharma Limited
04 22Boehringer Ingelheim GmbH
05 2Captavis Biocare
06 1Cipla
07 2Eignapharma S.L.
08 1Glenmark Pharmaceuticals
09 2Intas Pharmaceuticals
10 4Lotus Pharma Bulgaria Eood
11 2Lotus Pharmaceutical
12 2Newbury Pharmaceuticals Ab
13 2Olon S.p.A
14 2STADA Arzneimittel
15 2Sandoz B2B
16 1TEVA PHARMACEUTICALS DEVELOPMENT INC
17 3Teva Pharmaceutical Industries
18 2Zentiva
01 2CAP
02 5CAPSULE
03 8CAPSULE;ORAL
04 27Capsule
05 5Capsule, soft
06 1Nintedanib 100Mg 60 Units Oral Use
07 1Nintedanib 150Mg 60 Units Oral Use
08 2Oral Solid Dosage Form
09 2Soft Gel
10 2Soft Gelatin Capsule
11 4Blank
01 25Approved
02 1Available Dossier- US-EU-RoW
03 2Lead Market Dossiers- Under Development
04 2Originator
05 2RX
06 27Blank
01 9NINTEDANIB
02 2Nifibro
03 2Nintedanib Accord
04 2Nintedanib Eignapharma
05 2Nintedanib Lotus
06 2Nintedanib Newbury
07 2Nintedanib Reddy
08 2Nintedanib Sandoz
09 2Nintedanib Stada
10 2Nintedanib Teva
11 2Nintedanib Zentiva
12 4OFEV
13 11Ofev
14 1Ofev 100 mg
15 1Ofev 150 mg
16 3Vargatef
17 2Wolff
18 8Blank
01 4Australia
02 2Canada
03 6India
04 4Italy
05 5Norway
06 2South Africa
07 25Sweden
08 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000113
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 150mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000120
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 215123
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 100Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 150Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 150 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vargatef
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 212609
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212555
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
